Informations:
Erreur:
ID
30409
Description
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor; ODM derived from: https://clinicaltrials.gov/show/NCT01362972
Lien
https://clinicaltrials.gov/show/NCT01362972
Mots-clés
Versions (1)
- 03/06/2018 03/06/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
3 juin 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Lymphoma NCT01362972
Eligibility Lymphoma NCT01362972
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT01362972
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Inclusion Cohort Analysis | Criteria Fulfill
Item
for inclusion in the cohort analysis, patients must have data in the ebmt registry that meet the following criteria:
boolean
C1512693 (UMLS CUI [1,1])
C0086027 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
C0086027 (UMLS CUI [1,2])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Adult | Lymphoma | Multiple Myeloma
Item
adults diagnosed with lymphoma or multiple myeloma (mm)
boolean
C0001675 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
C0024299 (UMLS CUI [2])
C0026764 (UMLS CUI [3])
Autologous peripheral blood stem cell transplant First | Manipulation Stem cells
Item
received first autologous transplants of peripheral blood (pb) non ex-vivo manipulated stem cells in the time period listed above using cells mobilised with one of the following regimens:
boolean
C1960579 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
C0947647 (UMLS CUI [2,1])
C0038250 (UMLS CUI [2,2])
C0205435 (UMLS CUI [1,2])
C0947647 (UMLS CUI [2,1])
C0038250 (UMLS CUI [2,2])
Plerixafor | G-CSF
Item
plerixafor plus granulocyte colony stimulating factor (g-csf)
boolean
C1955474 (UMLS CUI [1])
C0079459 (UMLS CUI [2])
C0079459 (UMLS CUI [2])
Plerixafor | G-CSF | Chemotherapy
Item
plerixafor plus g-csf plus chemotherapy
boolean
C1955474 (UMLS CUI [1])
C0079459 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C0079459 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
G-CSF Alone
Item
g-csf alone or
boolean
C0079459 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,2])
G-CSF | Chemotherapy
Item
g-csf plus chemotherapy
boolean
C0079459 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0392920 (UMLS CUI [2])
Plerixafor Group | Therapeutic procedure in accordance with Label
Item
note: patients included in the plerixafor groups will be those treated according to the label
boolean
C1955474 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C4281991 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
C0441833 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C4281991 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
Informed Consent
Item
provision of informed consent (i.e., all patients with data in the ebmt registry will have signed consent at the time of transplantation for the potential use of their data for analysis)
boolean
C0021430 (UMLS CUI [1])
Plerixafor | Agreement European Union Label Lacking
Item
patients treated with plerixafor not according to the european union (eu) label.
boolean
C1955474 (UMLS CUI [1])
C0680240 (UMLS CUI [2,1])
C0015179 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
C0332268 (UMLS CUI [2,4])
C0680240 (UMLS CUI [2,1])
C0015179 (UMLS CUI [2,2])
C1705425 (UMLS CUI [2,3])
C0332268 (UMLS CUI [2,4])
Graft material ex vivo Manipulation
Item
patients whose graft product underwent ex vivo manipulation will be excluded from analysis
boolean
C0181074 (UMLS CUI [1,1])
C2348480 (UMLS CUI [1,2])
C0947647 (UMLS CUI [1,3])
C2348480 (UMLS CUI [1,2])
C0947647 (UMLS CUI [1,3])